Senores Pharmaceuticals Limited — Updates, 05-11-2025: General Updates
05-11-2025 | 06:41 pm
05-11-2025 | 06:41 pm
Senores Pharma's subsidiary, Havix, successfully resolved USFDA inspection observations and received an Establishment Inspection Report, indicating compliance. This positive development supports operational stability and market standing.
No comments yet. Be the first to comment!
